Physician profile
William Ward
NPI 1376106922
$9,654.24
in general payments reported to CMS, 2019-2025
44 companies · $2,565 in 2025
The $2,565 reported for 2025 was more than what 95% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,244 · 2022: $1,311 · 2023: $2,052 · 2024: $1,482 · 2025: $2,565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,098.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,617.95 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $1,063.43 | 2021-2025 | |
| Novo Nordisk INC | $706.27 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $622.57 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Amgen INC. | $596.50 | 2021-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $512.05 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $455.83 | 2021-2024 | Xarelto |
| Astellas Pharma US INC | $450.57 | 2021-2025 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $353.68 | 2021-2025 | Arexvy, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $338.62 | 2022-2025 | |
| Abbott Laboratories | $265.35 | 2021-2025 | Freestyle Libre 3 |
| Medtronic, INC. | $218.16 | 2025 | Minimed 780g |
| Otsuka America Pharmaceutical, INC. | $202.68 | 2023-2025 | Rexulti |
| Corium, LLC | $195.46 | 2022-2024 | Azstarys |
| Xeris Pharmaceuticals, INC. | $182.07 | 2022-2023 | Gvoke Hypopen |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.